Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations.

OBJECTIVE

To examine the degree and patterns of compliance with the Omnibus Budget Reconciliation Act (OBRA) regulations regarding the use of antipsychotic drugs in nursing homes.

DESIGN

Retrospective chart review of all resident records.

PARTICIPANTS

Eight nursing homes: five community, two county-owned, and one university-affiliated Veterans Administration facility.

MEASUREMENTS

A structured assessment instrument to track compliance with each aspect of the OBRA regulations regarding antipsychotic drug use.

RESULTS

A total of 1573 nursing home residents' pharmacy records were reviewed between August 1994 and March 1996. Two hundred seventy-nine residents were actively taking antipsychotic medications (prevalence = 17.7%). Mean compliance greater than 70% was found for (1) appropriate diagnostic indication (mean = 70.9%), (2) dosage within recommended limits (mean = 90.1%), and 3) documented appropriate target symptoms (mean = 90.4%). Dosages were more likely to exceed limits in those patients with histories of major mental illness, particularly schizophrenia.

CONCLUSIONS

Nursing homes were better able to comply with those guidelines that are most specific. Educational interventions now need to focus on behavioral interventions, monitoring of adverse effects, and efficacy. These data are useful in establishing threshold levels of performance and can be used by nursing homes for continuous quality improvement. OBRA continues to impact neuroleptic drug prescribing practices in nursing homes significantly.